Age, years (median, range): | ||
SpaceOAR | 70 (54–78) | p = 0.44 |
No-SpaceOAR | 66 (56–75) | |
PSA, ng/ml (median, range): | ||
SpaceOAR | 9.3 (6.6–19) | p = 0.08 |
No-SpaceOAR | 6.8 (4.2–12.7) | |
Risk Group (n / %): | ||
(Low/ Favorable Intermediate/Unfavorable Intermediate) | ||
SpaceOAR | 3 (30%) / 4 (40%) / 3 (30%) | |
No-SpaceOAR | 2 (20%) / 6 (60%) / 2 (20%) | |
Androgen deprivation therapy (n / %): | ||
SpaceOAR | 3 (30%) | |
No-SpaceOAR | 2 (20%) | |
Prostate Volume, cc (median, range): | ||
SpaceOAR | 62.5 (49.8–79) | p = 0.23 |
No-SpaceOAR | 55.5 (29.7–79) | |
Planning Target Volume, cc (median, range): | ||
SpaceOAR | 118.8 (85.7–150.1) p = 0.17 | |
No-SpaceOAR | 110.3 (70.9–145.3) | |
IPSS score (median, range): | ||
SpaceOAR | 7 (0–15)s | p = 0.14 |
No-SpaceOAR | 5 (0–10) |